Physician Photo

Mark C. Poznansky, MD, PhD

  • Phone: 617-726-3906
Infectious Diseases
Department of Medicine


  • Transplant Center
  • Transplant Infectious Disease
Boston: Massachusetts General Hospital
Medical Education
PhD, Cambridge University
MD, University of Edinburgh
Residency, St. Mary's Hospital
Fellowship, Brigham and Women's Hospital
Fellowship, Dana Farber Cancer Institute
Patient Age Group
Accepting New Patients
Accepting New Patients

Moving breakthroughs beyond the bench

MGH Hotline 1.23.09 The MGH is a hub of scientific research and discovery, but translating these breakthroughs into commercial applications can be a challenging and sometimes confusing process.

Consortium aims to accelerate vaccine creation

A newly created consortium plans to change the future of vaccine research.

VIC awarded funding for Type 1 diabetes research

The Vaccine & Immunotherapy Center (VIC) at the MGH is committed to projects that accelerate vaccine and immunotherapy development, including those dedicated to finding improved treatment options for people with Type 1 diabetes, an autoimmune disease in which a person’s pancreas stops producing insulin.

VIC joins consortium following groundbreaking diabetes research

The Vaccine and Immunotherapy Center at the MGH (VIC), has joined with 24 other institutions as part of the first-ever JDRF Encapsulation Consortium in the fight against type 1 diabetes.

Laser may increase vaccine effectiveness

New research indicates that using a particular laser to pre-treat the site of a flu shot may boost the body’s immune response against influenza.

Creating hope from loss

Inspired by his wife's memory, Jeffrey Gelfand, MD, and his MGH colleagues set out to create a vaccine to attack tumors in patients already diagnosed with cancer.

Mass. General Center Joins JDRF Consortium Following Groundbreaking Diabetes Research

The Vaccine and Immunotherapy Center at Massachusetts General Hospital (VIC), has joined with 24 other institutions as part of the first-ever JDRF Encapsulation Consortium in the fight against type 1 diabetes

Brief laser-light treatment may significantly improve effectiveness of influenza vaccines

Pretreating the site of intradermal vaccination – vaccine delivered into the skin rather than to muscles beneath the skin – with a particular wavelength of laser light may substantially improve vaccine effectiveness without the adverse effects of chemical additives currently used to boost vaccine efficacy.

Novel cancer vaccine holds promise against ovarian cancer, mesothelioma

A novel approach to cancer immunotherapy may provide a cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma. A protein engineered by MGH investigators to combine a molecule targeting a tumor antigen with an immune-function stimuating protein prolonged survival in animal models of both tumors.

Protein that repels immune cells protects transplanted pancreatic islets from rejection

An approach developed by MGH investigators may provide a solution to the limitations that have kept pancreatic islet transplantation from meeting its promise as a cure for type 1 diabetes.

Mass. General-led consortium focusing on rapid development of Q fever vaccine

A consortium of academic and industry organizations led by a team from the MGH Vaccine and Immunotherapy Center has launched a new effort to develop an entirely new type of vaccine against Q fever.

Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-3906